2011
DOI: 10.4267/2042/45042
|View full text |Cite
|
Sign up to set email alerts
|

t(1;11)(p32;q23)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
2
0

Year Published

2016
2016
2016
2016

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 18 publications
0
2
0
Order By: Relevance
“…Thirty-eight percent of reported leukemia patients with t(1;11)(p32;q23) were infants equally distributed between acute lymphoblastic leukemia (ALL) and AML. 5,6 This translocation was also seen in monozygotic twins with ALL and therapy-related ALL. 7,8 No cases of spontaneously resolving leukemia with t(1;11)(p32;q23) have been reported.Leukemia cutis is noted frequently at the onset of disease; rare cases preceding diagnosis were reported, likely at the aleukemic phase.…”
mentioning
confidence: 87%
See 1 more Smart Citation
“…Thirty-eight percent of reported leukemia patients with t(1;11)(p32;q23) were infants equally distributed between acute lymphoblastic leukemia (ALL) and AML. 5,6 This translocation was also seen in monozygotic twins with ALL and therapy-related ALL. 7,8 No cases of spontaneously resolving leukemia with t(1;11)(p32;q23) have been reported.Leukemia cutis is noted frequently at the onset of disease; rare cases preceding diagnosis were reported, likely at the aleukemic phase.…”
mentioning
confidence: 87%
“…While AML with the t(1;11)(q21;q23) has 100% overall survival rate in childhood, the prognosis of t(1;11)(p32;q23) AML was dismal with a median survival of 15 months. Thirty‐eight percent of reported leukemia patients with t(1;11)(p32;q23) were infants equally distributed between acute lymphoblastic leukemia (ALL) and AML . This translocation was also seen in monozygotic twins with ALL and therapy‐related ALL .…”
mentioning
confidence: 99%